Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Pharma

Imagine a future where leveraging our DNA and what we know about it prevents illness and improves care outcomes.

Co-Founder and CEO, Genome Medical, and 2020 Tom Main Health Innovation Mentorship Winner

And How Stakeholders Can, Literally, Save the World

Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.

Director, Marsh & McLennan Advantage Insights
Partner, Health and Life Sciences, Oliver Wyman

New Predictions on COVID-19 Vaccines and Herd Immunity

How COVID-19 case counts and vaccines may get us back to normalcy by June.

Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Software-only products providing free-standing treatment represent a key healthcare opportunity for incumbents.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Social distancing may be necessary for two years or more. Here's where remote care comes into play.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Specialty drugs represent an opportunity to better serve patients, but also pose risks.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Actuarial, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare

The recent rise of custom-made drugs is already redefining the state of regulation, society, and the economy.

Researcher, PreScouter

In our rearview mirror is a ten-year stretch of experimentation. What looms ahead is the rewriting of healthcare's rules.

Partner, Health and Life Sciences, Oliver Wyman
Former Partner, Health & Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Whoever's closest to the consumer will be the gatekeeper of the industry.

Principal, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman
Principal, Oliver Wyman
Senior Consultant, Oliver Wyman

Three percent of consumers drive 70 percent of pharmacy spend. Pharmacy is ripe for change.

Former Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Senior Advisor, Oliver Wyman

Insights in your inbox

Subscribe